Market closed

iRhythm/$IRTC

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About iRhythm

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

Ticker

$IRTC
Sector
Health Care
Trading on
NASDAQ

Industry

Health Care Equipment & Supplies
Headquarters
San Francisco, United States

Employees

2,000
Website
www.irhythmtech.com

iRhythm Metrics

BasicAdvanced
$3B
-
-$4.85
1.23
-

$3B

1.23

$124.12

$55.92

319K

6.273

5.988

1,003.038

1,024.666

-9.23%

-8.93%

-103.34%

5.242

41.24

41.74

-33.578

18.45%

40.63%

20.53%

21.77%

What the Analysts think about iRhythm

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for iRhythm stock.

iRhythm Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

iRhythm Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-

iRhythm News

AllArticlesVideos
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation

Accesswire·14 hours ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect

Accesswire·2 days ago
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewsWire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $IRTC

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for iRhythm stock?

iRhythm (IRTC) has a market cap of $3B as of January 15, 2025.

What is the P/E ratio for iRhythm stock?

The price to earnings (P/E) ratio for iRhythm (IRTC) stock is 0 as of January 15, 2025.

Does iRhythm stock pay dividends?

No, iRhythm (IRTC) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next iRhythm dividend payment date?

iRhythm (IRTC) stock does not pay dividends to its shareholders.

What is the beta indicator for iRhythm?

iRhythm (IRTC) has a beta rating of 1.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.